KEKlaus Empen

Klaus Empen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Klaus Empen has a total of 135 co-authors. Here are the top co-authors by number of shared publications:

  • Marcus Dörr

    Department of Internal Medicine B, University Medicine Greifswald , Greifswald

    6 shared publications
  • Stephan B. Felix

    Medizinische Klinik B Universitätsmedizin Greifswald Germany

    5 shared publications
  • Stephan Burkhard Felix

    Department of Internal Medicine B, University Medicine Greifswald, 17475 Greifswald, Germany

    5 shared publications
  • Henry Völzke

    Institute for Community Medicine, University Medicine Greifswald , Greifswald

    3 shared publications
  • Thorsten Reffelmann

    From the Department of Internal Medicine (K.E., M.D., S.G., T.R., R.E., S.B.F.), Institute for Community Medicine (R.L., H.V.), Institute for Clinical Chemistry and Laboratory Medicine (R.H., M.N., A.K., H.W.), Ernst Moritz Arndt University, Greifswald, Germany

    3 shared publications
  • Alexander Krebs

    From the Department of Internal Medicine (K.E., M.D., S.G., T.R., R.E., S.B.F.), Institute for Community Medicine (R.L., H.V.), Institute for Clinical Chemistry and Laboratory Medicine (R.H., M.N., A.K., H.W.), Ernst Moritz Arndt University, Greifswald, Germany

    2 shared publications

Latest Publications

  • Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

    by Gerrit Toenges, Anna C Mavromanoli, Stefano Barco, Walter Ageno, Hélène Bouvaist, Marianne Brodmann, Claudio Cuccia, Francis Couturaud, Claudia Dellas, Konstantinos Dimopoulos, et al.


  • Open Access

    Takayasu’s arteritis: a case with relapse after urgent coronary revascularization

    by Klaus Empen, Astrid Hummel, Daniel Beug, Stephan B. Felix, Mathias C. Busch, Piotr M. Kaczmarek

    Vasculitides are commonly unrecognized causes of coronary stenosis and myocardial ischemia. We report on a 24-year old patient with Takayasu’s arteritis who underwent urgent percutaneous coronary intervention, suffered from symptomatic restenosis of the left main coronary artery during standard immunosuppressive therapy. A 24-year old woman was referred for coronary angiography because of typical progressive angina pectoris. On bicycle ergometry, there were both reproducible symptoms and deep ST segment depressions on precordial leads. Semi-selective angiography of the left coronary artery revealed high-grade ostial stenosis. Because of persistent angina pectoris and electrocardiographic signs of acute myocardial ischemia, immediate percutaneous coronary angioplasty with subsequent implantation of an everolimus-eluting stent was performed. This intervention was performed with excellent angiographic results. Because of several concomitant criteria including hypoechogenicity on postprocedural intravascular ultrasonography, the diagnosis of Takayasu’s disease was made. The patient was treated with prednisolone and cyclophosphamide for 5 months. Because of recurrent angina pectoris, another coronary angiography was performed, which revealed high-grade in-stent-restenosis. Immunomodulatory therapy was switched to high-dose prednisolone and the anti-IL-6 receptor antagonist tocilizumab. The high-grade in-stent-restenosis persisted, and aortocoronary bypass graft surgery was performed with two saphenous vein grafts to the left anterior descending and circumflex artery. Since then, the patient has been doing well for 2 years. In cases of treatment refractoriness during standard immunosuppressive therapy, more recently developed biological compounds may offer an alternative strategy.


  • Open Access

    Non-Thrombotic Fatal Pulmonary Embolism with a ‘Rule-Out’ Ct Scan

    by Daniel Beug, Sigrun Friesecke, Stephan B. Felix, Klaus Empen

    We report on a 36-year-old woman suffering from metastasized breast cancer and severe dyspnoea owing to right heart failure. Symptoms and findings were highly suggestive of pulmonary embolism. In rare cases, pulmonary embolism is caused not by migration of venous thrombi but by emboli of other origin. Patients with cancer can suffer from non-thrombotic pulmonary embolism, either by (macroscopic) embolization of tumour mass or by microembolism also known as microscopic tumour microangiopathy. In patients with cancer with clinical presentation highly suggestive of pulmonary embolism, with echocardiographic findings confirming right ventricular dysfunction, and with negative CT angiography, pulmonary tumour microembolism should be considered as possible diagnosis.


  • Multicenter Long-Term Validation of a Minicourse in Radiation-Reducing Techniques in the Catheterization Laboratory

    by Eberhard Kuon, Kerstin Weitmann, Wolfgang Hoffmann, Marcus Dörr, Astrid Hummel, Alexander Riad, Mathias C. Busch, Stephan B. Felix, Klaus Empen


  • Proteome analysis of heart biopsies using a TRIzol-based protein extraction

    by Cristina Pop, Sabine Ameling, Klaus Empen, Julia Rüdebusch, Vishnu Mukund Dhople, Stephan B. Felix, Felicia Loghin, Uwe Völker, Elke Hammer


    • 1 April 2014
      • Vol. 26  (4) , 148-53

    A novel flow-based parameter of collateral function assessed by intracoronary thermodilution.

    by Markus Lindner, Stephan B Felix, Klaus Empen, Thorsten Reffelmann

    Currently, many methods for quantitation of coronary collateral function are based on intracoronary pressure measurements distal of an occluded balloon, which do not fully account for the dynamic nature of collateral flow. Therefore, a flow-based parameter of coronary collateral function based upon principles of thermodilution was evaluated. In 26 patients with a high-grade coronary artery stenosis, intracoronary hemodynamics were analyzed by the RadiAnalyzer system (St Jude Medical), including fractional flow reserve (FFR), index of microcirculatory resistance (IMR), and the pressure-based collateral flow index (CFI) during balloon occlusion and hyperemia (intravenous adenosine). Moreover, immediately after an intracoronary bolus of room-temperature saline, the balloon was occluded and the intracoronary temperature distal to the balloon was analyzed over time. The slope of the temperature-time curve was calculated after logarithmic transformation as an index of collateral blood flow (CBFI). The coefficient of variation between two measurements of CBFI amounted to 11 ± 2%. In patients with CFI ≥0.25, CBFI amounted to 0.55 ± 0.09, whereas in those with CFI <0.25, CBFI was 0.37 ± 0.03. CBFI correlated significantly with CFI (r = 0.65; P<.001). Interestingly, in the subgroup with IMR below the median (<14.2 mm Hg · s), the slope of the linear regression for CBFI vs CFI was steeper than in individuals with higher IMR, which indicates more effective collateral flow for any given intracoronary pressure distal to the occluded balloon in the group with lower microvascular resistance. This novel index might be useful as a flow-based index of collateral function, and should be evaluated in further studies.

  • How should I treat severe paravalvular leakage after TAVI?

    by Markus Reinthaler, Klaus Empen, Mathias Busch, Raik Könemann, Hüseyin Ince, Stephan B. Felix, Hasan Jilaihawi, Tarun Chakravarty, Raj R. Makkar, Olaf Franzen, et al.

    The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)


  • Open Access

    Do patients with type 1 and type 2 diabetes really have an impaired endothelial function? A population-based propensity score matching analysis

    by Klaus Empen, Roberto Lorbeer, Henry Völzke, Thorsten Reffelmann, Sabine Schipf, Matthias Nauck, Wolfgang Kerner, Henri Wallaschofski, Stephan B Felix, Marcus Dörr

    Previous studies suggested an impaired endothelial function in patients with diabetes. However, the validity of this finding may be limited by the lack of adequate adjustment for further cardiovascular confounders. We assessed endothelial function as measured by flow-mediated dilation (FMD) of the brachial artery in patients with either type 1 or type 2 diabetes in comparison with non-diabetic controls.


  • Association of Testosterone Levels With Endothelial Function in Men

    by Klaus Empen, Roberto Lorbeer, Marcus Dörr, Robin Haring, Matthias Nauck, Sven Gläser, Alexander Krebs, Thorsten Reffelmann, Ralf Ewert, Henry Völzke, et al.

    Objective—: Because population-based data are lacking, we assessed the cross-sectional association between serum testosterone levels and endothelial function, as measured by flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) of the brachial artery, in men from the population-based Study of Health in Pomerania. Methods and Results—: Personal characteristics, including major cardiovascular confounders, were collected in 722 men, aged 25 to 85 years. Serum total testosterone and sexual hormone-binding globulin (SHBG) levels were determined by chemiluminescence immunoassays. Free testosterone levels were calculated according to the law of mass action. FMD and NMD measurements were performed using standardized ultrasound techniques. FMD and NMD values below the 20th percentile were considered decreased. Multivariable logistic regression analyses revealed an association for each decrement of total testosterone standard deviation (6.0 nmol/L) with decreased FMD after adjustment for potential confounders (odds ratio 1.30, 95% confidence interval 1.04–1.63; P =0.023). Multiple adjusted findings for free testosterone were similar (odds ratio 1.37, 95% confidence interval 1.06–1.76; P =0.016). There was no such association of SHBG levels with decreased FMD. Neither testosterone nor SHBG levels were significantly associated with decreased NMD. Conclusion—: Lower serum total and free testosterone levels are associated with impaired endothelial function in this population-based sample of men.


  • Open Access

    Peripheral endothelial dysfunction is associated with gas exchange inefficiency in smokers

    by Sven Gläser, Anne Obst, Christian F Opitz, Marcus Dörr, Stephan B Felix, Klaus Empen, Henry Völzke, Ralf Ewert, Christoph Schäper, Beate Koch

    To assess the cross-sectional association between exercise capacity, gas exchange efficiency and endothelial function, as measured by flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) of the brachial artery, in a large-scale population-based survey. The study population was comprised of 1416 volunteers 25 to 85 years old. Oxygen uptake at anaerobic threshold (VO2@AT), peak exercise (peakVO2) and ventilatory efficiency (VE vs. VCO2 slope and VE/VCO2@AT) were assessed on a breath-by-breath basis during incremental symptom-limited cardiopulmonary exercise. FMD and NMD measurements at rest were performed using standardised ultrasound techniques. Multivariable logistic regression analyses revealed a significant association between FMD and ventilatory efficiency in current smokers but not in ex-smokers or non-smokers. There was no association between FMD and VO2@AT or peak VO2. In current smokers, for each one millimetre decrement in FMD, VE/VCO2@AT improved by -3.6 (95% CI -6.8, -0.4) in the overall population [VE vs. VCO2 slope -3.9 (-7.1, -0.6)]. These results remained robust after adjusting for all major influencing factors. Neither exercise capacity nor ventilatory efficiency was significantly associated with NMD. In current smokers, FMD is significantly associated with ventilatory efficiency. This result may be interpreted as a potential clinical link between smoking and early pulmonary vasculopathy due to smoking.